secwatch.observer — SEC 8-K summary
======================================

Issuer:     KORU Medical Systems, Inc. (KRMD)
CIK:        0000704440
Form:       8-K
Filed at:   2026-11-10T21:43:30+00:00
Accession:  0001161697-26-000243
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

KORU Medical Q3 revenue $11.6M, up 11%; net income $0.2M, second straight positive quarter
--------------------------------------------------------------------------------

- Net revenues $11.57M (+11.2% YoY); gross margin 65.2% vs 60.2%; gross profit $7.5M (+20.5%).
- Domestic core revenue $8.06M (+31.6%); international core $3.08M (-16.5%); pharma services $0.42M (-27.4%).
- Net income $0.2M ($0.00 diluted) vs prior-year net loss of $0.8M (-$0.02); adjusted EBITDA $1.3M vs $0.1M.
- FY2026 revenue guidance narrowed to $48.0-48.5M (17-18% growth) from $47.5-48.5M; gross margin raised to 63-64%.
- Signed two new sales and distribution agreements in Europe and Africa; year-end cash guidance raised to >$8.0M from >$7.5M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/704440/000116169726000243/0001161697-26-000243-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/704440/000116169726000243/form_8-k.htm
  HTML page:      https://secwatch.observer/filing/0001161697-26-000243

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer